To improve care, policy analysts and health leaders recommend there be fewer and narrower quality measures.
To improve care, policy analysts and health leaders recommend there be fewer and narrower quality measures.
Tom Daschle, former Senate majority leader from South Dakota, and Michael Leavitt, former governor of Utah and Department of Health and Human Services Secretary under George W. Bush, say that in order for the US healthcare system to transition to a focus on value, a unified group of measures is necessary.
“The dilemma we are having in driving quality measurement is we are still trying to fuss with the little gears,” Leavitt said. “We are going to have to discover the big gears and turn them. That’s all the consumer has interest in dealing with.”
Currently, providers manage about 1370 different performance measures, and many are unaligned. With policy reform initiatives such as HITECH and the Affordable Care Act, that number is subject to increase.
Leavitt adds, “You can implement just about any system in time. We’ve been going through a complicated, labored implementation. But you have to ask the question now, `is it working, and how can we make it better where it’s not working?’”
Quantifying quality benchmarks is important, especially as changes to the sustainable growth rate formula will impact Medicare incentive programs. In addition to providers receiving a 0.5% annual increase in reimbursement and other bonuses, the newly minted merit-based incentive payment system will combine the Physician Quality Reporting System along with meaningful use and value-based payment modifier programs.
“This legislation represents a major milestone in physicians’ nearly 10-year battle to repeal the flawed sustainable growth rate formula used to calculate Medicare reimbursement,” said David W. Parke II, MD, CEO of the American Academy of Ophthalmology. “The Academy applauds the efforts of the members of the Senate Committee on Finance, the House Committee on Ways and Means, and the House Committee on Energy and Commerce for their efforts in developing this bipartisan legislation. Ophthalmology joins our colleagues across medicine in strongly urging lawmakers to pass this legislation in order to protect the viability of physicians’ practices and ensure beneficiaries have access to the highest quality medical and surgical care available.”
Around the Web
Leaders Press for Fewer Quality Measures [Healthcare IT News]
Support for SGR Repeal Bill Builds Among Physician Societies [EHR Intelligence]
Contributor: North Carolinians Worked Together to Enact Medicaid. Our Collaboration Can’t End Now.
December 5th 2023The sustained, collaborative effort to expand Medicaid will improve the lives of working North Carolinians who, prior to enactment, earned too much to qualify for Medicaid, but not enough to afford insurance on the marketplace.
Read More
Oncology Onward: A Conversation With Thyme Care CEO and Cofounder Robin Shah
October 2nd 2023Robin Shah, CEO of Thyme Care, which he founded in 2020 with Bobby Green, MD, president and chief medical officer, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, to discuss his evolution as an entrepreneur in oncology care innovation and his goal of positively changing how patients experience the cancer system.
Listen
What We’re Reading: Affordable Home Care; Mycoplasma Infections Rise; Opioid Crisis Settlement
December 4th 2023Families struggle to find affordable, reliable home health aides; reports of increased pediatric pneumonia cases; legal battle ensues over Purdue Pharma’s bankruptcy settlement.
Read More
Insufficient Data, Disparities Plague Lung Cancer Risk Factor Documentation
September 24th 2023On this episode of Managed Care Cast, we speak with the senior author of a study published in the September 2023 issue of The American Journal of Managed Care® on the importance of adequate and effective lung cancer risk factor documentation to determine a patient's eligibility for screening.
Listen
New Data Update Myasthenia Gravis Outcomes for Patients in Australia
December 3rd 2023Patients living with myasthenia gravis in Australia were surveyed their demographic information, clinical features of the autoimmune disease, adverse effects from treatment, and quality of life. Outcomes were compared against 2011 data from Australia and 2019 data from the United States.
Read More
NK Cell Therapy SNK01 Improves Cognitive Function in Alzheimer Disease for up to 11 Weeks
December 3rd 2023Among 10 patients evaluated, compared with their baseline at 1 week after receiving their final dose in the trial, 30% demonstrated clinical improvement on the Alzheimer’s disease composite score.
Read More